BioTrinity 2014 Conference

Monday, May 12th, -Wednesday  May 14th, 2014

Novotel London West, 1 Shortlands, London W6 8DR, UK

OBN's annual BioTrinity partnering and investment conference is a key diary date for senior R&D executives, big pharma licensing and development managers, and biomedical investors. Now in its eighth year, BioTrinity 2014 is, according to the organisers, promising to bring together more active participants than any other European one-to-one partnering conference, confirming increased attendee numbers from corporate ventures and strategic investors, as well as growing participation from the medtech community. The list of high-calibre presenters presages the quality of discussion and partnering opportunities that participants may expect. 

Over 100 European R&D companies will showcase their unique assets and technologies. Ten expert panel discussions featuring industry pundits will debate the future of life science partnering and investment. Over 2000 one-to-one meetings, workshops and social networking events are vital opportunities for forming and fostering strategic relationships. 

BioTrinity boasts a level of informal interaction unique to this event, a legacy of its roots as an industry membership organisation conference. Although a record 1000+ delegates are expected this year, BioTrinity will retain its friendly, boutique atmosphere - come and join us!!